Literature DB >> 4435675

Combined thyroid (triiodothyronine)-tricyclic antidepressant treatment in depressive states.

C Ogura, T Okuma, Y Uchida, S Imai, H Yogi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4435675     DOI： 10.1111/j.1440-1819.1974.tb02300.x

Source DB:  PubMed          Journal:  Folia Psychiatr Neurol Jpn        ISSN： 0015-5721


× No keyword cloud information.
  5 in total

Review 1.  Drug treatment of depression in HIV-positive patients : safety considerations.

Authors:  Andrew A Pieper; Glenn J Treisman
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 2.  Safety considerations in drug treatment of depression in HIV-positive patients: an updated review.

Authors:  Crystal C Watkins; Andrew A Pieper; Glenn J Treisman
Journal:  Drug Saf       Date:  2011-08-01       Impact factor: 5.606

3.  Cerebrospinal fluid amine metabolites after combined amitriptyline-triiodothyronine treatment of depressed women.

Authors:  C M Banki
Journal:  Eur J Clin Pharmacol       Date:  1977-04-20       Impact factor: 2.953

Review 4.  Hormone treatment of depression.

Authors:  Russell T Joffe
Journal:  Dialogues Clin Neurosci       Date:  2011       Impact factor: 5.986

Review 5.  Liothyronine for Depression: A Review and Guidance for Safety Monitoring.

Authors:  Katie T B Touma; Allysa M Zoucha; Jonathan R Scarff
Journal:  Innov Clin Neurosci       Date:  2017-04-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.